Combined Expression of Metastasis Related Markers Naa10p, SNCG and PRL-3 and its Prognostic Value in Breast Cancer Patients |
Min, Li
(Department of Biochemistry and Molecular Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education))
Ma, Ruo-Lan (Department of Thoracic Surgery, Peking University Cancer Hospital and Institute) Yuan, Hua (Breast Center, Peking University Cancer Hospital and Institute) Liu, Cai-Yun (Department of Biochemistry and Molecular Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education)) Dong, Bing (Department of Pathology, Peking University Cancer Hospital and Institute) Zhang, Cheng (Department of Biochemistry and Molecular Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education)) Zeng, Yan (Department of Biochemistry and Molecular Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education)) Wang, Li (Department of Biochemistry and Molecular Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education)) Guo, Jian-Ping (Department of Biochemistry and Molecular Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education)) Qu, Li-Ke (Department of Biochemistry and Molecular Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education)) Shou, Cheng-Chao (Department of Biochemistry and Molecular Biology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education)) |
1 | Al-Aidaroos A and Zeng Q (2010). PRL-3 phosphatase and cancer metastasis. J Cell Biochem, 111, 1087-98. DOI |
2 | Amsterdam A, Shezen E, Raanan C, et al (2012). Differential staining of gamma synuclein in poorly differentiated compared to highly differentiated colon cancer cells. Oncol Rep, 27, 1451-4. |
3 |
Arnesen T, Kong X, Evjenth R, et al (2005). Interaction between HIF- |
4 | Bauer J, Shin D, Chun Y, et al (2009). Arrest defective-1 controls tumor cell behavior by acetylating myosin light chain kinase. PLoS ONE, 4, 7451. DOI ScienceOn |
5 |
Bilton R (2005). Arrest-defective-1 protein, an acetyltransferase, does not alter stability of hypoxia-inducible factor (HIF)- |
6 | Cox C, Shamehdi C and Glancy J (2011). Sentinel node micrometastasis in breast cancer: clinically significant or not? Breast J, 17, 335-6. DOI |
7 | Czekierdowski A, Czekierdowska S, Wielgos M, et al (2006). The role of CpG islands hypomethylation and abnormal expression of neuronal protein synuclein-gamma (SNCG) in ovarian cancer. Neuro Endocrinol Lett, 27, 381-6. |
8 | Franceschini A, Szklarczyk D, Frankild S, et al (2012). STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res, 41, 808-15. |
9 |
Gromyko D, Arnesen T, Ryningen A, et al (2010). Depletion of the human |
10 | Guo J, Shou C, Meng L, et al (2007). Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer. Int J Cancer, 121, 1296-305. DOI |
11 | Guzinska-Ustymowicz K, Kisluk J, Terlikowski S, et al (2013). Expression of phosphatase of regenerating liver-3 (PRL-3) in endometrioid cancer and lymph nodes metastases. Adv Med Sci, 1, 7-12. |
12 | Guzinska-Ustymowicz K, Pryczynicz A, Kemona A, Ustymowicz M (2011). Immunohistochemical assessment of PRL-3 (PTP4A3) expression in tumor buds, invasion front, central region of tumor and metastases of colorectal cancer. Adv Med Sci, 56, 39-43. DOI |
13 | Hibi T, Mori T, Fukuma M, et al (2009). Synuclein-gamma is closely involved in perineural invasion and distant metastasis in mouse models and is a novel prognostic factor in pancreatic cancer. Clin Cancer Res, 15, 2864-71. DOI |
14 | Holmes M, Chen W, Li L, et al (2010). Aspirin intake and survival after breast cancer. J Clin Oncol, 28, 1467-72. DOI |
15 | Jemal A, Bray F, Center M, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
16 |
Hua K, Tan C, Johansson G, et al (2011). N- |
17 | Inaba S, Li C, Shi Y, et al (2005). Synuclein inhibits the mitotic checkpoint function and promotes chromosomal instability of breast cancer cells. Breast Cancer Res Treat, 94, 25-35. DOI |
18 | Jafferbhoy S, McWilliams B (2012). Clinical significance and management of sentinel node micrometastasis in invasive breast cancer. Clin Breast Cancer, 12, 308-12. DOI |
19 | Jeong J, Bae M, Ahn M, et al (2002). Regulation and destabilization of HIF-1 alpha by ARD1. Cell, 111, 709-20. DOI |
20 | Jia T, Liu Y, Liu J, et al (1999). Stimulation of breast cancer invasion and metastasis by synuclein gamma. Cancer Res, 59, 742-7. |
21 | Kuo H, Lee D, Chen C, et al (2010). ARD1 Stabilization of TSC2 suppresses tumorigenesis through the mTOR signaling pathway. Sci Signal, 3, 9. |
22 | Lee C, Ou D, Lee S, et al (2010). hNaa10p contributes to tumorigenesis by facilitating DNMT1-mediated tumor suppressor gene silencing. J Clin Invest, 120, 2920-30. DOI |
23 |
Lim J, Park J, Chun Y (2006). Human arrest defective 1 acetylates and activates |
24 | Liu C, Dong B, Lu A, et al (2010). Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigen. BMC Cancer, 10, 359. DOI |
25 | Ohkawa N, Sugisaki S, Tokunaga E, et al (2008). N-acetyltransferase ARD1-NAT1 regulates neuronal dendritic development. Genes Cells, 13, 1171-83. |
26 |
Min L, Xu H, Wang J, et al (2013). N- |
27 | Ming J, Liu N, Gu Y, et al (2009). PRL-3 facilitates angiogenesis and metastasis by increasing ERK phosphorylation and up-regulating the levels and activities of Rho-A/C in lung cancer. Pathol, 41, 118-26. DOI |
28 |
Murrayrust T, Oldham N, Hewitson K, et al (2006). Purified recombinant hARD1 does not catalyse acetylation of Lys532 of HIF- |
29 |
Ohkawa N, Sugisaki S, Tokunaga E, et al (2007). ARD1-NAT1 complex regulates neuronal dendritic arborization through |
30 | Pan Z, Bruening W and Godwin A (2006). Involvement of RHO GTPases and ERK in synuclein-gamma enhanced cancer cell motility. Int J Oncol, 29, 1201-5. |
31 | Peng L, Xing X, Li W, et al (2009). PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin beta1-ERK1/2 and-MMP2 signaling. Mol Cancer, 8, 110. |
32 | Polato F, Codegoni A, Fruscio R, et al (2005). PRL-3 phosphatase is implicated in ovarian cancer growth. Clin Cancer Res, 11, 6835-9. DOI |
33 | Polymeropoulos M, Lavedan C, Leroy E, et al (1997). Mutation in the gamma-synuclein gene identified in families with parkinson's disease. Science, 276, 20457. |
34 | Siegel R, Naishadham D and Jemal A (2012). Cancer statistics, 2012. CA Cancer J Clin, 62, 10-29. DOI ScienceOn |
35 | Rahimzadeh M, Baghestani A, Gohari M, Pourhoseingholi M (2014). Estimation of the cure rate in Iranian breast cancer patients. Asian Pac J Cancer Prev, 15, 4839-42. DOI ScienceOn |
36 | Saini K, Taylor C, Ramirez A, et al (2011). Role of the multidisciplinary team in breast cancer management: results from a large international survey involving 39 countries. Ann Oncol, 23, 853-9. |
37 | Seo J, Cha J, Park J, et al (2010). Arrest defective 1 autoacetylation is a critical step in its ability to stimulate cancer cell proliferation. Cancer Res, 70, 4422-32. DOI |
38 | Singh V, Zhou Y, Marsh J, et al (2007). Synuclein-gamma targeting peptide inhibitor that enhances sensitivity of breast cancer cells to antimicrotubule drugs. Cancer Res, 67, 626-33. DOI |
39 | Surgucheva I, Park B, Yue B, et al (2005). Interaction of myocilin with gamma-synuclein affects its secretion and aggregation. Cell Mol Neurobiol, 25, 1009-33. DOI |
40 | Vairaktaris E, Yapijakis C, Serefoglou Z, et al (2008). Gene expression polymorphisms of interleukins-1 beta, -4, -6, -8, -10, and tumor necrosis factors-alpha, -beta: regression analysis of their effect upon oral squamous cell carcinoma. J Cancer Res Clin Oncol, 134, 821-32. DOI |
41 | Wang L (2006). Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome. Ann Oncol, 17, 1517-22. DOI |
42 | Wang Z, He Y, Cai S, et al (2008). Expression and prognostic impact of PRL-3 in lymph node metastasis of gastric cancer: its molecular mechanism was investigated using artificial microRNA interference. Int J Cancer, 123, 1439-47. DOI |
43 | Zheng P, Liu Y, Chen L, et al (2010). Stathmin, a new target of PRL-3 identified by proteomic methods, plays a key role in progression and metastasis of colorectal cancer. J Proteome Res, 9, 4897-905. DOI |
44 | Wu K, Huang S, Zhu M, et al (2013). Expression of synuclein gamma indicates poor prognosis of triple-negative breast cancer. Med Oncol, 30, 612. DOI |
45 | Zeng Y, Liu C, Dong B, et al (2013). Inverse correlation between Naa10p and MMP-9 expression and the combined prognostic value in breast cancer patients. Med Oncol, 30, 562. DOI |
![]() |